1. Home
  2. NRIX vs INOD Comparison

NRIX vs INOD Comparison

Compare NRIX & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$18.51

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Innodata Inc.

INOD

Innodata Inc.

HOLD

Current Price

$64.00

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRIX
INOD
Founded
2009
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2020
1993

Fundamental Metrics

Financial Performance
Metric
NRIX
INOD
Price
$18.51
$64.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
3
Target Price
$27.46
$91.67
AVG Volume (30 Days)
1.8M
1.0M
Earning Date
01-27-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
62.46
EPS
N/A
1.01
Revenue
$83,687,000.00
$238,467,000.00
Revenue This Year
$59.40
$48.85
Revenue Next Year
N/A
$25.93
P/E Ratio
N/A
$64.39
Revenue Growth
48.32
73.57
52 Week Low
$8.18
$26.41
52 Week High
$22.50
$93.85

Technical Indicators

Market Signals
Indicator
NRIX
INOD
Relative Strength Index (RSI) 55.34 65.23
Support Level $16.98 $50.90
Resistance Level $19.54 $55.18
Average True Range (ATR) 0.91 3.03
MACD -0.34 1.89
Stochastic Oscillator 57.04 88.95

Price Performance

Historical Comparison
NRIX
INOD

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

About INOD Innodata Inc.

Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.

Share on Social Networks: